Apolipoprotein A-I gene expression is regulated by cellular zinc status in Hep G2 cells

The influence of Zn on the expression of the apolipoprotein A-I(apoA-I) gene in Hep G2 cells was examined. Zn depletion was achievedwith a low-Zn (ZD) medium prepared from Zn-free growth medium(Opti), a ZD medium containing Chelex 100-extracted fetal bovine serum (CHE), and a medium containing chelator1,10-phenanthroline (OP). Compared with those for their respectivecontrols, cellular Zn levels were reduced by 55, 48, and 46% andapoA-I mRNA abundances were reduced by 20, 29, and 28% in Opti, CHE,and OP systems, respectively, after one passage in ZD media or 24 h inOP medium. To establish the specificity of Zn treatment, groups of ZDcells were treated with their respective control media for the last 24 h (ZDA) or normal cells were cultured with OP medium supplemented withZn (OP-Zn). ZDA treatments partially normalized cellular Zn levels inthe Opti system and restored or elevated apoA-I mRNA levels in the Optior CHE system, respectively. Similarly, the OP-Zn treatment restoredthe cellular Zn and apoA-I mRNA levels. Furthermore, one passage ofculture with Zn-supplemented media in both the Opti and CHE systemsresulted in higher cellular Zn and apoA-I mRNA levels than those forcontrols. Most significantly, short-term high-Zn induction to normalcells markedly elevated the cellular Zn (3-fold) and apoA-I mRNA(5-fold) levels. Data derived from this study strongly suggest that theexpression of apoA-I is regulated by cellular Zn status.

     

Calmodulin — And its role in cellular activation

The cellular protein calmodulin activates, in the presence of calcium ions, several functions and enzymes in eukaryotic cells. Calmodulin binds calcium and magnesium, and various calcium-calmodulin complexes bind to and activate both enzymes that regulate cellular calcium or cyclic nucleotides and specific protein kinases that regulate target enzymes by ATP-dependent phosphorylation. General principles of calmodulin activation are reviewed. The calmodulin-dependent enzymes show complicated activation kinetics and, in particular cases, the transitions between non-activated and activated enzyme states exhibit time-lag and hysteretic behaviour.     

A cytosolic domain of the yeast Zrt1 zinc transporter is required for its post-translational inactivation in response to zinc and cadmium

Nutrient metals such as zinc are both essential to life and potentially toxic if overaccumulated by cells. Non-essential toxic metals like cadmium can enter cells through the uptake transporters responsible for nutrient metal acquisition. Therefore, in the face of ever changing extracellular metal levels, organisms tightly control their intracellular levels of nutrient metals and prevent accumulation of toxic metals. We show here that post-translational inactivation of the yeast Zrt1 zinc uptake transporter is important for zinc homeostasis. During the transition from zinc-limiting to zinc-replete growth conditions (i.e. zinc shock), the Zrt1 transporter is ubiquitinated, endocytosed, and subsequently degraded in the vacuole. To further understand this process at a molecular level, we mapped a region of Zrt1 required for ubiquitination and endocytosis in response to zinc to a domain located on the intracellular surface of the plasma membrane. This domain is a critical cis-acting component of the metal signaling pathway that controls Zrt1 protein trafficking. Using mutant alleles defective for metal-responsive inactivation, we also show that Zrt1 inactivation may be an important mechanism for preventing cadmium uptake and toxicity in zinc-limited cells.     

Soluble expression and purification of tumor suppressor WT1 and its zinc finger domain

Full length murine WT1 and its zinc finger domain were separately inserted into Escherichia coli expression vectors with various fusion tags on either terminus by Gateway technology (Invitrogen) and expression of soluble protein was assessed. Fusion proteins including the four zinc finger domains of WT1 were used to optimize expression and purification conditions and to characterize WT1:DNA interactions in the absence of WT1:WT1 interactions. Zinc finger protein for in vitro characterization was prepared by IMAC purification of WT1 residues 321-443 with a thioredoxin-hexahistidine N-terminal fusion, followed by 3C protease cleavage to liberate the zinc fingers and cation exchange chromatography to isolate the zinc fingers and reduce the level of the truncated forms. Titration of zinc finger domain with a binding site from the PDGFA promoter gave a K(d) of 100±30nM for the -KTS isoform and 130±40nM for the +KTS isoform. The zinc finger domain was also co-crystallized with a double-stranded DNA oligonucleotide, yielding crystals that diffract to 5.5?. Using protocols established for the zinc finger domain, we expressed soluble full-length WT1 with an N-terminal thioredoxin domain and purified the fusion protein by IMAC. In electro-mobility shift assays, purified full-length WT1 bound double-stranded oligonucleotides containing known WT1 binding sites, but not control oligonucleotides. Two molecules of WT1 bind an oligonucleotide presenting the full PDGFA promoter, demonstrating that active full-length WT1 can be produced in E. coli and used to investigate WT1 dimerization in complex with DNA in vitro.     

HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression

HIV-1 Tat protein reprograms cellular gene expression of infected as well as uninfected cells apart from its primary function of transactivating HIV-1 long terminal repeat (LTR) promoter by binding to a nascent RNA stem–loop structure known as the transactivator response region (TAR). Tat also induces chromatin remodeling of proviral LTR-mediated gene expression by recruiting histone acetyl transferases to the chromatin, which results in histone acetylation. Furthermore several studies have shown convincing evidence that Tat can transactivate HIV-1 gene expression in the absence of TAR, the molecular mechanism of which remains to be elucidated. Here we show a direct interaction of Tat with nuclear factor kappa B (NFκB) enhancer, a global regulatory sequence for many cellular genes both in vitro and in vivo. This interaction not only provides a novel molecular basis to explain TAR-independent transactivation in HIV-1, but also points toward the potential mechanism of Tat- mediated modulation of cellular genes.     

The role of connexins in controlling cell growth and gene expression

The purpose of this paper is to provide a brief overview of current thinking on the role of connexins, in particular Cx43, in growth regulation, and a more detailed discussion as to potential mechanisms involved with an emphasis on gene expression. While the precise molecular mechanism by which connexins can affect the growth of normal or tumor cells remains elusive, a number of exciting reports have expanded our understanding and are presented in some detail. Thus, we will discuss (Section 2): the role of protein-protein interactions in integrating connexins into multiple signal transduction pathways; phosphorylation at specific sites and reversal of growth inhibition; the role of the carboxy-terminal regulatory domain as a signaling molecule. Some of our latest work on the potential functions of endogenously produced carboxy-terminal fragments of Cx43 are also presented (Section 3). Finally, Section 4 will pay tribute to the rapidly emerging realization that connexins such as Cx43 and Cx32 exert important and extensive effects on gene expression, particularly those genes linked to growth regulation.     

Glucose up-regulates HIF-1 alpha expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status

It has been suggested that hypoxia-inducible factor 1 (HIF-1), a key regulator in cell's adaptation to hypoxia, plays an important role in the fate of neurons during ischemia. However, the mechanism of HIF-1 regulation is still not fully understood in neurons subjected to ischemia. In this study, we demonstrated that glucose up-regulated the expression of HIF-1α, the oxygen-dependent subunit of HIF-1, in rat primary cortical neurons exposed to hypoxia. To understand the mechanism of glucose-regulated HIF-1α expression, we investigated the relationships between HIF-1α expression, reactive oxygen species (ROS), and redox status. Low levels of HIF-1α protein expression were observed in the neurons exposed to in vitro ischemic conditions that had high levels of ROS (oxidizing environments), and vice versa . The glutathione (GSH) precursor, N -acetyl cysteine, induced HIF-1α protein expression in hypoxic neurons while the GSH synthesis inhibitor, l -buthionine sulfoximine, inhibited the expression. Moreover, (−)-epicatechin gallate, a ROS scavenger, elevated HIF-1α expression in the neurons subjected to in vitro ischemia. Furthermore, results from a systemic hypoxia model showed that a reducing environment increased HIF-1α expression in rat brains. Taken together, these data presented the first evidence that glucose promoted HIF-1α stabilization through regulating redox status in primary neurons exposed to hypoxia. The results imply that hypoxia only may not be sufficient to stabilize HIF-1α and that a reducing environment is required to stabilize HIF-1α in neurons exposed to hypoxia.